Top Story

Bisphosphonate treatment did not reduce risk for postmenopausal breast cancer

August 21, 2014

Treatment with bisphosphonates for osteoporosis provided no protective effect against the risk for invasive postmenopausal breast cancer, according to an analysis of results from two randomized, double blind, placebo-controlled trials.

These results contradict findings from observational studies that suggest bisphosphonates may suppress the proliferation of estrogen-sensitive breast cancer cells.

figure In the Journals

Digital surveillance, photography aided early melanoma diagnosis

August 21, 2014
Surveillance with total body photography and sequential digital dermoscopy imaging helped improve early detection of primary melanomas, according to study…
figure In the Journals

Pemetrexed plus cisplatin active in advanced, recurrent cervical carcinoma

August 21, 2014
The combination of pemetrexed and cisplatin appeared safe and effective in women with advanced, persistent or recurrent carcinoma of the cervix, according to results of…
figure In the Journals

Regular transfusions reduced stroke recurrence in pediatric sickle cell anemia

August 20, 2014
Children with sickle cell anemia who underwent regular blood-transfusion therapy experienced fewer recurrences of cerebral infarct, according to results of a…
More News Headlines »
In Practice

The state of the science: Starting a dialogue about HSCT

HemOnc Today, June 10, 2014
William Wood, MD
In 2013, Science magazine designated cancer immunotherapy as its breakthrough of the year.
More »
Meeting News Coverage Video

Docetaxel plus ADT improved OS in metastatic prostate cancer

June 24, 2014
CHICAGO — Donald L. Trump, MD, FACP, president and CEO at Roswell Park Cancer Institute and HemOnc Today
More »